European journal of hospital pharmacy : science and practice
Evaluation of the impact of NOAC underdosing and exploration of bleeding risk factors in elderly patients with atrial fibrillation: artificial intelligence-based approach.
Dorian Protzenko, Cecile Berard, Vincent Hoang, Guillaume Hache
Published: 202610.1136/ejhpharm-2025-004610
Abstract
OBJECTIVE: Atrial fibrillation in elderly patients increases the risk of thromboembolism, necessitating long-term anticoagulation. While non-vitamin K oral anticoagulants (NOACs) are generally preferred, appropriate dosing in older patients who are f…
Preview only. Read the full abstract at the source